All News #Library
Biotech
Ventus Therapeutics Nominates VENT-04 as First-in-Class Candidate
07 Jan 2026 //
BUSINESSWIRE
Ventus Launches Phase 2 Trial of VENT-03 cGAS Inhibitor in Lupus
10 Dec 2025 //
BUSINESSWIRE

Market Place
Sourcing Support